CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission
A single infusion of mivocabtagene autoleucel, a CD19 chimeric antigen receptor T-cell therapy, put severe, treatment-refractory rheumatoid arthritis into sustained remission in three out of six patients at Charité—Universitätsmedizin Berlin. … Read More